Published in World J Urol on September 05, 2007
Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation (2008) 1.50
Proteomic signatures in plasma during early acute renal allograft rejection. Mol Cell Proteomics (2010) 1.14
A "crossomics" study analysing variability of different components in peripheral blood of healthy caucasoid individuals. PLoS One (2012) 0.86
Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients. Transplant Res (2012) 0.81
Proteomics for rejection diagnosis in renal transplant patients: Where are we now? World J Transplant (2016) 0.76
Non-invasive diagnosis of acute rejection in renal transplant patients using mass spectrometry of urine samples - a multicentre phase 3 diagnostic accuracy study. BMC Nephrol (2015) 0.76
Heat Shock Protein 90α Is a Potential Serological Biomarker of Acute Rejection after Renal Transplantation. PLoS One (2016) 0.75
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med (2005) 5.02
Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med (2003) 4.35
Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant (2004) 4.06
Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant (2006) 3.58
Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med (2001) 3.16
Mass spectrometry and the age of the proteome. J Mass Spectrom (1998) 2.59
Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant (2004) 2.35
Infiltrates in protocol biopsies from renal allografts. Am J Transplant (2007) 2.24
Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant (2003) 1.76
Prediction of acute renal allograft rejection by urinary monokine induced by IFN-gamma (MIG). J Am Soc Nephrol (2005) 1.72
Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol (2004) 1.67
Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg (2003) 1.54
Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol (1998) 1.54
Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant (2006) 1.50
Increased expression of cytotoxic effector molecules: different interpretations for steroid-based and steroid-free immunosuppression. Pediatr Transplant (2003) 1.48
Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int (2004) 1.48
Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am J Transplant (2005) 1.39
Safety and adequacy of renal transplant protocol biopsies. Am J Transplant (2005) 1.30
Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am J Transplant (2005) 1.24
Bioinformatic analysis of the urine proteome of acute allograft rejection. J Am Soc Nephrol (2004) 1.23
Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function. Kidney Int (2006) 1.21
Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction. Am J Transplant (2004) 1.19
Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation (1998) 1.13
Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation (2004) 1.07
CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation (2003) 1.07
Quantitative detection of T-cell activation markers by real-time PCR in renal transplant rejection and correlation with histopathologic evaluation. Transplantation (2002) 1.02
Elevated numbers of circulating endothelial cells in renal transplant recipients. Transplantation (2003) 1.00
Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors. Transplantation (2001) 0.99
Urine macrophage migration inhibitory factor concentrations as a diagnostic tool in human renal allograft rejection. Transplantation (2001) 0.97
Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation (2003) 0.96
Heightened expression of the cytotoxicity receptor NKG2D correlates with acute and chronic nephropathy after kidney transplantation. Am J Transplant (2006) 0.96
Humoral rejection of organ allografts. Am J Transplant (2005) 0.94
Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion. Am J Transplant (2007) 0.92
Circulating endothelial cells are a novel marker of cyclosporine-induced endothelial damage. Hypertension (2003) 0.92
Improved diagnosis of early kidney allograft dysfunction by ultrasound with echo enhancer--a new method for the diagnosis of renal perfusion. Nephrol Dial Transplant (2006) 0.91
Cytokine and cytotoxic molecule gene expression determined in peripheral blood mononuclear cells in the diagnosis of acute renal rejection. Transplantation (2000) 0.90
An increase in myeloid-related protein serum levels precedes acute renal allograft rejection. J Am Soc Nephrol (2001) 0.90
CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients. Transplantation (2003) 0.85
Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection. Transplantation (2000) 0.85
Molecular signatures of urinary cells distinguish acute rejection of renal allografts from urinary tract infection. Transplantation (2003) 0.85
Metabolomics in monitoring kidney transplants. Curr Opin Nephrol Hypertens (2006) 0.84
Serial evaluation of cell surface markers for immune activation after acute renal allograft rejection by urine flow cytometry--correlation with clinical outcome. Transplantation (2001) 0.83
Renal allograft rejection: the temporal relationship and predictive value of plasma TNF (alpha and beta), IFN-gamma and soluble ICAM-1. Transpl Int (1995) 0.83
Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts. Nephrol Dial Transplant (2002) 0.83
Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejection. Kidney Int (2003) 0.83
The value of posttransplant monitoring of interleukin (IL)-2, IL-3, IL-4, IL-6, IL-8, and soluble CD23 in the plasma of renal allograft recipients. Transplantation (1995) 0.82
Immune monitoring in organ transplantation using neopterin. Curr Drug Metab (2002) 0.82
Clinical predictors of chronic renal allograft rejection. Kidney Int Suppl (1995) 0.82
Beta-2-microglobulin for differentiation between ciclosporin A nephrotoxicity and graft rejection in renal transplant recipients. Nephron (1989) 0.81
New markers in serum for lymphocyte activation for predicting allograft rejection. Neopterin and soluble interleukin-2 receptor. Clin Lab Med (1992) 0.81
Renal expression of CD44 correlates with acute renal allograft rejection. Kidney Int (2006) 0.81
Cellular and molecular parameters in human renal allograft rejection. Clin Biochem (2001) 0.81
Rationale and application of beta-2-microglobulin measurements to detect acute transplant rejection. Nephron (1981) 0.81
Protocol biopsy: what is the rationale and what is the evidence? Nephrol Dial Transplant (2003) 0.81
Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection. Transplantation (2003) 0.81
Serum & urinary interleukin-2 levels as predictors in acute renal allograft rejection. Indian J Med Res (2004) 0.80
Heightened peripheral blood lymphocyte CD69 expression is neither sensitive nor specific as a noninvasive diagnostic test for renal allograft rejection. J Am Soc Nephrol (2003) 0.80
Differential diagnosis of kidney transplant rejection and cyclosporin/tacrolimus nephropathy using urine cytology. Clin Transplant (2002) 0.80
Developing a tool for noninvasive monitoring of renal allografts. Expert Rev Proteomics (2006) 0.80
Interleukin-8 expression in patients after renal transplantation. Am J Kidney Dis (1997) 0.79
Tissue viral DNA is associated with chronic allograft nephropathy. Pediatr Transplant (2005) 0.78
Interleukin-6 expression after renal transplantation. Nephrol Dial Transplant (1997) 0.78
Non-invasive monitoring of renal transplant recipients: urinary excretion of soluble adhesion molecules and of the complement-split product C4d. Nephron Clin Pract (2003) 0.77
Soluble e-selectin, ICAM-1, and VCAM-1 levels in renal allograft recipients. Transplant Proc (1994) 0.75
Clinical graft evolution of lymphocytes, polymorphonuclear cells, and antigen expression in tubular renal cells in the urine sediment of 20 renal allograft recipients. Transplant Proc (2003) 0.75
Matching T-cell receptors identified in renal biopsies and urine at the time of acute rejection in pediatric renal transplant patients. Am J Transplant (2004) 0.75
Flow cytometric evaluation of cytotoxic peripheral blood lymphocytes in acute renal graft rejection. J Am Soc Nephrol (1992) 0.75
Urine cytology and urine flow cytometry in renal transplantation--a prospective double blind study. Transplantation (1995) 0.75
An assessment of serum and urine soluble interleukin-2 receptor concentrations during renal transplant rejection. Am J Kidney Dis (1994) 0.75